![]() |
Introducing SVM's Novel Anticoagulant Course
Novel anticoagulants are opening up choices for the treatment of vascular disease.
|
Pharmacology of the New Agents | New Therapies in Atrial Fibrillation |
New Directions in Venous Thromboembolism |
Case Discussion Panelists |
Impact of Novel Agents on a Hospital’s Budget and Anticoagulation Service |
The P&T Committee Response to the $10/Day Pill, Locally and Nationally and Question and Answer Discussion with Panel |
| Members: Full Course $175 | Nonmembers: Full Course $195 |
Not yet an SVM Member? Join today and save on this and all SVM educational programs.
Learn more.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of University of Colorado School of Medicine (UCSM) and SVM. UCSM is accredited by the ACCME to provide continuing medical education for physicians. UCSM designates this activity for a maximum of 4.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Accreditation for Pharmacists
TG Medical Education, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity provides 4 hours (0.4 CEUs) of continuing pharmacy education credit.
Questions?
Society for Vascular Medicine
111 Deer Lake Road, Suite 100
Deerfield, IL 60015 USA
Tel: +1-847-480-2961
info@vascularmed.org